1 / 22

PENTHROX ™ - Methoxyflurane History and Experience in the Management of Pain

PENTHROX ™ - Methoxyflurane History and Experience in the Management of Pain. Clinical Need. Inherent need to offer patients analgesia for existing or potential pain Current options: Local anaesthetics, oral analgesics, narcotics and …. Clinical Need.

keelty
Télécharger la présentation

PENTHROX ™ - Methoxyflurane History and Experience in the Management of Pain

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. PENTHROX™ - Methoxyflurane History and Experience in the Management of Pain

  2. Clinical Need • Inherent need to offer patients analgesia for existing or potential pain • Current options: • Local anaesthetics, oral analgesics, narcotics • and …

  3. Clinical Need • Current analgesic options may be less than ideal due to: • Limited efficacy • Inconvenient administration • Length of onset or duration of action • Adverse reactions (e.g., respiratory depression)

  4. Methoxyflurane • Originally a general anaesthetic agent • Now Contraindicated due to safety concerns with dose • Unique in producing powerful analgesic properties at verylow sub-anaesthetic concentrations • Currently indicated for trauma and minor surgical procedures • Needs NO pre-medication • or fasting

  5. Features of Methoxyflurane • Potent analgesic with rapid onset • (6 – 10 breaths) • Demonstrated cardiovascular and • respiratory stability • No significant adverse effects • Can be administered easily to patients • of virtually all ages

  6. Penthrox™ Inhaler • The Penthrox™ Inhaler is a tubular light-weight disposable inhaler device that features: • Internal wick (absorption matrix) • Dilutor hole enables two concentrations • One-way valve to prevent blow-back • 22mm mouthpiece – connects to face mask

  7. Use intermittently as needed, or just before planned possible painful stage during intervention Intermittent Usage of Methoxyflurane

  8. Best to empower the patient to self-administer intermittently Gentle assistance/direction as needed Patient may close eyes as they relax, rarely drowsy – easily roused Recovery is quick Assisting the Patient to Manage Pain

  9. Clinical Studies • The analgesic safety and efficacy of methoxyflurane has been evaluated in a variety of areas: • Pre-hospital • Emergency • Burns • Dental • Obstetrics • Aesthetic surgery

  10. Case Series (Buntine, 2007) • 83 adult patients receiving paramedical assistance and transport to urban teaching hospital • Age range = 17 to 95 years • Methoxyflurane administered via Penthrox™ Inhaler • Administration duration = median of 29 minutes • Indication included musculoskeletal injury, visceral pain and back pain

  11. Case Series (Buntine): Results Statistically significant reduction in pain scores compared with baseline (p < 0.0001)

  12. Case Series (Babl, 2006): • 105 paediatric patients receiving paramedical assistance and transport to tertiary children’s hospital • Age range = 15 months to 17 years • Methoxyflurane administered via Penthrox Inhaler • Administration duration = median of 20 minutes • No pre-medications, no food or fluid restrictions

  13. Case Series (Babl): Results • Methoxyflurane administration resulted in a 43.0% reduction in pain scores within 10 minutes • 88.5% of paramedics were satisfied to very satisfied with the level of patient analgesia • 87.0% of patients were satisfied to very satisfied with the level of analgesia • 96.9% of primary care providers and older patients would want to use Methoxyflurane again for pain control

  14. Clinical Poster (Wilkes and Oxer, 2007): • 17,344 patients receiving paramedical assistance and transport to hospital • Age range = 2 years to 95+ years • Methoxyflurane administered via Penthrox Inhaler = 13,313 patients • Fentanyl administered intra-nasally = 4,021 patients • No pre-medications, no food or fluid restrictions

  15. Clinical Poster (Wilkes and Oxer): Results • No significant side effects reported • Methoxyflurane particularly useful in children • Analgesia from methoxyflurane found to be equivalent to intra-nasal fentanyl

  16. Examples of Use – Ambulance and Rescue • Physical trauma • Domestic trauma • Motor vehicle accidents • Pain / injury • Mass casualty • Emergency rescue

  17. Hospital • Accident and emergency • Minor surgical procedures • Burns / wound management • Radiology • Oncology • Acute pain services

  18. First Response • Worksite injuries • Sporting injuries • Injuries at mass public • gatherings • Physical trauma • Mass Trauma • Remote Areas

  19. Methoxyflurane Use – Severe Burns • Patient with severe burns and excruciating pain – immersed in water to cool • Immediate relief from suffering • watch patient’s face • Clinical team can immediately treat patient

  20. Potential Population • Patients who may benefit include those: • In pain • Anxious • Pain intolerant • Dislike of needles or injections • Uncooperative • Preparing for a painful • procedure

  21. Summary Methoxyflurane has been clinically demonstrated over many years to be a safe and effective agent offering patients comfort and relief from pain

More Related